G-Ipra Nebuliser Solution
Ipratropium Bromide
250mcg/ml
Gonoshasthaya Pharmaceuticals Ltd.
| Pack size | 20ml vial |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 55.00 AED |
Indications
G-Ipra Nebuliser Solution is used for:
Asthma, chronic obstructive pulmonary disease, chronic bronchitis, emphysema.
Adult Dose
Inhalation
Asthma; Chronic obstructive pulmonary disease
Adult: As Inhaler: Adults: 1-2 puffs (20 mg/puff) 3-4 times daily. Single doses of up to 80 mcg may be required in some patients.
As nebulized soln
250-500 mcg 3-4 times daily.
Child Dose
Inhalation
Asthma; Chronic obstructive pulmonary disease
Child: As metered-dose aerosol:
<6 yr 20 mcg tid;
6-12 yr 20-40 mcg tid.
As soln for nebulisation:
<6 yr For acute asthma: 125-250 mcg, given no more often than 6 hrly up to a total dose of 1 mg.
6-12 yr For acute and chronic asthma: 250 mcg, repeated as necessary up to a total dose of 1 mg.
Renal Dose
Administration
Contra Indications
Ipratropium Bromide solution should not be taken by patients with known hypersensitivity to atropine or its derivatives or to any other component of the product.
Precautions
Bladder neck obstruction, narrow-angle glaucoma or patients susceptible to glaucoma, prostatic hyperplasia. Protect patient's eyes from nebulised drug. Renal and hepatic impairment. Pregnancy, lactation, children, elderly.
Pregnancy-Lactation
Pregnancy category: B
Lactation: Unknown whether drug is excreted in breast milk
Interactions
Increased toxicity with other anticholinergic drugs.
Adverse Effects
Side effects of Ipratropium Bromide :
Dry mouth, urinary retention, buccal ulceration, paralytic ileus, headache, nausea, constipation, paradoxical bronchospasm, immediate hypersensitivity reactions (urticaria, angioedema), acute angle-closure glaucoma.
Potentially Fatal: Anaphylactic reactions, atrial fibrillation, supraventricular tachycardia.
Mechanism of Action
Ipratropium bromide blocks the action of acetylcholine at parasympathetic sites in bronchial smooth muscle causing bronchodilation.
Note
G-Ipra 250mcg/ml Nebuliser Solution manufactured by Gonoshasthaya Pharmaceuticals Ltd.. Its generic name is Ipratropium Bromide. G-Ipra is availble in Bangladesh.
Farmaco BD drug index information on G-Ipra Nebuliser Solution is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.
Some other brands of Ipratropium Bromide :
Inhaler
Ipramid
20mcg
Beximco Pharmaceuticals Ltd.
Inhaler
Ipramid HFA
20mcg
Beximco Pharmaceuticals Ltd.
Nebuliser Solution
Ipratop 0.25
0.25 mg/ml
Incepta Pharmaceuticals Ltd.
Aerosol Inhalation
Iprex
20mcg
Square Pharmaceuticals PLC.
Respirator Solution
Iprex Respiratory Solution
250mcg/ml
Square Pharmaceuticals PLC.